Invitrogen to acquire Sentigen

SGHL gained $0.54 (20%) to $3.29 after IVGN said it plans to acquire the company for $3.37 per share, or $25.9 million in cash. The deal price is a 23% premium to SGHL's close of $2.75 on Thursday. IV...